However, a single study demonstrating the diagnostic potential of ENO1 autoantibodies in childhood B-ALL showed detectable serum anti-ENO1 in 27% of patients compared to only 4% of controls [45]. This evidence concerns the gene ENO1 and precursor B-cell acute lymphoblastic leukemia.